Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 465.00
Prev. Close: 465.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Issue of Equity

22 Jul 2020 16:43

RNS Number : 8056T
Tristel PLC
22 July 2020
 

Tristel plc

("Tristel" or the "Company")

Director/PDMR Shareholding and Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of share options by certain directors it has issued and allotted 878,629 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). To meet the exercise cost and associated tax liabilities, the directors have subsequently sold 548,629 Ordinary Shares at a price of 404.2 pence per share. In addition, Paul Barnes, Non-Executive Director, has sold 336,095 Ordinary Shares at a price of 404.2 pence per share.

In summary:

Director

Total number of share options exercised

Number of Ordinary Shares sold

Resultant Shareholding

Percentage of the Company's issued share capital held

Remaining number of options held

Paul Swinney

487,097

320,431

643,095

1.4%

166,666

Liz Dixon

331,532

198,198

178,334

0.4%

133,334

Paul Barnes

30,000

351,095

30,000

0.1%

15,000

David Orr

30,000

15,000

43,191

0.1%

15,000

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 29 July 2020. 

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company. Following the above exercise of options, the Company's issued share capital consists of 46,175,162 Ordinary Shares. Accordingly, the figure of 46,175,162 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

 Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

 

Liz Dixon, Finance Director

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

 

 

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

 

Giles Rolls (Corporate Finance)

 

Alice Lane (ECM)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Swinney

2.

Reason for the Notification.

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

487,097

 

Sale Price(s)

Volume(s)

404.2p

320,431

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Liz Dixon

2.

Reason for the Notification.

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

331,532

 

Sale Price(s)

Volume(s)

404.2p

198,198

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Barnes

2.

Reason for the Notification.

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

30,000

 

Sale Price(s)

Volume(s)

404.2p

351,095

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Orr

2.

Reason for the Notification.

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

30,000

 

Sale Price(s)

Volume(s)

404.2p

15,000

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUUCMUPUGAP
Date   Source Headline
3rd Jul 20177:00 amRNSSubmission to EPA & subsidiary incorporated in USA
13th Jun 20177:00 amRNSIssue of Equity
24th May 20177:00 amRNSShareholder Open Day & Notice of Trading Update
19th May 20173:34 pmRNSIssue of Equity
3rd May 20178:27 amRNSIssue of Equity
7th Apr 20175:04 pmRNSResult of Placing
7th Apr 20172:07 pmRNSProposed Secondary Placing
28th Mar 20172:38 pmRNSIssue of Equity
7th Mar 20179:41 amRNSIssue of Equity
6th Mar 20177:00 amRNSIssue of Equity
27th Feb 20177:00 amRNSProducts approved by Australia's TGA
27th Feb 20177:00 amRNSJournal of Ultrasound in Medicine & Biology
23rd Feb 20177:00 amRNSHalf-year Report
25th Jan 20177:00 amRNSInvestor results presentation
24th Jan 20177:00 amRNSJournal of Infection Prevention: TSTL wipes study
17th Jan 201712:31 pmRNSDirector / PDMR Shareholding
13th Dec 201612:30 pmRNSResult of AGM
13th Dec 20167:00 amRNSAGM Statement
6th Dec 20167:00 amRNSIssue of Equity
28th Nov 20163:42 pmRNSNotice of AGM correction
23rd Nov 201612:37 pmRNSIssue of Equity
17th Oct 20167:00 amRNSFinal Results
13th Oct 20168:33 amRNSIssue of Equity
12th Oct 20168:12 amRNSStudy shows Tristel Wipes System benefits
11th Oct 20167:00 amRNSStudy shows Tristel Wipes System benefits
20th Sep 20167:00 amRNSNotice of Results
19th Sep 20169:24 amRNSIssue of Equity
12th Sep 20167:00 amRNSRegulatory approval in Australia for surface range
19th Aug 20164:30 pmRNSDirector/PDMR Shareholding
19th Aug 20161:30 pmRNSIssue of Equity
21st Jul 20163:26 pmRNSDirector Dealing
21st Jul 20167:00 amRNSTrading update, Special dividend & Acquisition
25th May 20167:00 amRNSShareholder Open Day & Notice of Trading Update
29th Apr 201611:06 amRNSDirector Dealing
26th Apr 201610:06 amRNSDirector Dealing
15th Mar 20167:00 amRNSDirector Dealing
11th Mar 20167:00 amRNSDirector Dealing
10th Mar 20167:00 amRNSDirector Dealing
2nd Mar 20165:13 pmRNSDirector Dealing
2nd Mar 20169:46 amRNSDirector Dealing
29th Feb 20167:00 amRNSDirector Dealing
26th Feb 20169:43 amRNSDirectors Dealings
24th Feb 20167:00 amRNSHalf Yearly Report
25th Jan 20167:00 amRNSNotice of Results
13th Jan 20164:53 pmRNSIssue of Equity
5th Jan 20167:00 amRNSTransition of German branch to subsidiary status
15th Dec 20151:43 pmRNSDirectors Dealings
15th Dec 201512:18 pmRNSResult of AGM
15th Dec 20157:00 amRNSAGM Statement
2nd Dec 201511:37 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.